Cannabis 'MS' drug decision urged

Medicine regulators have been accused of dragging their feet over a cannabis drug for people with multiple sclerosis. The Medicines and Healthcare Regulatory Agency (MHRA) met last week to discuss Sativex, a medicinal form of cannabis. It decided more clinical data was needed before the drug could be approved for treating muscle stiffness in MS

read more | digg story